IM Cannabis (NASDAQ:IMCC) Posts Earnings Results, Beats Estimates By $0.16 EPS

IM Cannabis (NASDAQ:IMCC) released its quarterly earnings results on Monday. The company reported ($0.23) EPS for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.16, Zacks reports. IM Cannabis had a negative net margin of 25.55% and a negative return on equity of 129.86%.

IM Cannabis Price Performance

IMCC stock opened at $1.74 on Monday. IM Cannabis has a 12-month low of $1.61 and a 12-month high of $8.10. The company has a current ratio of 0.70, a quick ratio of 0.59 and a debt-to-equity ratio of 0.10. The firm’s 50-day moving average price is $2.05 and its two-hundred day moving average price is $2.28. The stock has a market capitalization of $3.87 million, a price-to-earnings ratio of -0.51 and a beta of 1.03.

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands.